Status:
NOT_YET_RECRUITING
Acoustic Resonance Therapy for Treating Empty Nose Syndrome
Lead Sponsor:
Stanford University
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Empty Nose Syndrome
Nasal Obstruction
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
This study is to determine whether Acoustic Resonance Therapy (ART), an FDA-approved treatment for standard nasal obstruction, may be helpful in mitigating the debilitating symptoms of Empty Nose Synd...
Eligibility Criteria
Inclusion
- Documented case of Empty Nose Syndrome
- Documented past turbinate reduction surgery
Exclusion
- Neurocognitive diagnosis/decline
Key Trial Info
Start Date :
July 1 2028
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2030
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT07215013
Start Date
July 1 2028
End Date
July 1 2030
Last Update
October 10 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Stanford, California, United States, 94305
2
Ohio State University
Columbus, Ohio, United States, 43210